Xyosted 100 MG/0.5 ML auto-INJ 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F73TJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,457
Award facts
- Contract value 100% obligated
- $6,457.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,457.14 delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies, with an ultimate completion date of January 8, 2026. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical procurement system, supplying essential medications and medical devices to military treatment facilities, veterans' healthcare programs, and other government medical institutions. The delivery order for Xyosted, a testosterone replacement therapy auto-injector, reflects the company's role in fulfilling specialized pharmaceutical requirements across multiple therapeutic domains. The non-set-aside competitive award demonstrates AmerisourceBergen's capability to meet federal procurement standards through open competition, consistent with its extensive portfolio of federal medical product deliveries to the Defense Logistics Agency and allied government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F73TJ?
SPE2DR26F73TJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F73TJ worth?
The government has obligated $6,457 on SPE2DR26F73TJ.
Is contract SPE2DR26F73TJ an order under another contract?
Yes. SPE2DR26F73TJ is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F73TJ competed?
The extent of competition for SPE2DR26F73TJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award